Miranda Martin+FollowViking’s Weight Loss Pill Drops Pounds—But at a CostViking’s new obesity pill VK2735 helped people lose over 12% of their body weight in just 13 weeks—sounds amazing, right? But here’s the catch: nearly 1 in 5 dropped out because of side effects like nausea and vomiting. Investors were hoping for a miracle drug, but the safety profile was a letdown, and Viking’s stock tanked 40%. Would you risk the side effects for the weight loss? #Fitness #weightloss #pharma00Share
awaters+FollowWill Your Meds Get Pricier? EU-US DramaHeads up: A new EU-US trade deal could mean your prescription meds might cost more soon. Why? For the first time, big-name drugs crossing the Atlantic could get hit with a 15% tax. That’s billions in extra costs for pharma companies, and some of it could trickle down to us at the pharmacy. Some companies are stockpiling meds or cutting deals to dodge the worst, but until the ink dries on this deal, it’s a waiting game for your wallet. #Business #Industry #pharma20Share
Keith Bass+FollowWould You Trust a $15B Health Team-Up?Big pharma’s playing matchmaker again! Summit Therapeutics might join forces with AstraZeneca in a partnership worth up to $15 billion. If this deal goes through, it could mean faster new medicines and more treatment options hitting your local pharmacy shelves. But with big money on the table, you have to wonder—will patients see the benefits, or just bigger price tags? #Business #EntrepreneurshipStartup #pharma01Share
margaret39+FollowWeight-Loss Drug Drama: Dose Matters!Amgen’s new weight-loss shot, MariTide, is making waves—but not all good ones. Early trials showed almost 90% of people got sick (literally) when starting on the highest dose. Now, Amgen’s switching it up: lower starting doses, slow increases, and hoping for fewer side effects. The kicker? People still lost up to 20% of their body weight! But with all the nausea, is it worth it? Would you try a monthly shot if it meant serious weight loss? #WeightLoss #HealthNews #Pharma #Fitness110Share
Stephanie Snow+FollowEU Eyes Sodium Oxybate MedsThe EU is taking a closer look at some meds with sodium oxybate, which are used for alcohol withdrawal and narcolepsy. They’re checking if these drugs are as safe as we think. If you or someone you know relies on these, keep an eye out for updates—things could change soon! #HealthNews #EU #Pharma #Health #BodyHealth00Share
reyesbrian+FollowCheaper Meds, Shorter Lives?Would you trade lower drug prices for a shorter life? A new study says if the U.S. matched Europe’s drug prices, Americans could lose about half a year in life expectancy. The catch? Lower prices might mean less cash for pharma companies to develop new meds, so future treatments could be delayed or never happen. It’s a wild trade-off between saving money now and living longer later! #DrugPrices #Healthcare #Pharma #LifeExpectancy #HotTake #Health00Share
Stephanie Snow+FollowEMA’s mRNA Vaccine Rulebook Drops!Big news for anyone following vaccine tech: the EMA just dropped a draft guideline on how mRNA vaccines (like the ones used for COVID) should be made and tested. It covers everything from what counts as starting material (think DNA templates and nucleotides) to how to prove your vaccine is stable and safe. There’s even a focus on new delivery systems and multivalent vaccines. Developers have until Sept 2025 to weigh in! #mRNA #VaccineNews #Pharma #Regulations #EMA #Health00Share
Keith Stokes+Follow5 Wild Healthcare Breakthroughs This WeekDid you see the FDA just approved the first-ever gene therapy for a rare skin disorder? Plus, there’s a new treatment for giant cell arteritis that could help patients ditch steroids. Myasthenia gravis got a new med, semaglutide is showing promise for MASH, and a global study found high teen blood sugar could mean bigger heart risks later. Healthcare is moving FAST—these headlines are game-changers! #HealthcareNews #FDAApprovals #MedicalBreakthroughs #GeneTherapy #Pharma #Health391Share
Alexis Nicholson+FollowWHO’s Big Move on Weight-Loss MedsThe WHO is about to officially back weight-loss drugs like Wegovy and Zepbound for adults battling obesity—huge news since over a billion people worldwide are affected. But here’s the catch: these meds can cost over $1,000 a month and might need to be taken for life. WHO’s also pushing for ways to make them more affordable, especially in lower-income countries, and is considering adding them to its essential medicines list. Cheaper generics could be coming soon! #weightloss #WHO #healthnews #obesity #medications #pharma #Health152Share
Stephanie Snow+FollowWhy Are Rx Costs So Out of Control?Ever feel like you need a PhD just to afford your meds? Prescription prices are skyrocketing, and insurance hoops are making it worse—40% of scripts now cost $250+ per fill! Even though pharma companies pour billions into patient assistance, barely anyone gets help. Experts say we need tech-driven, seamless solutions (think: 1-click shopping, but for meds) and real teamwork across the healthcare system. Until then, patients are stuck paying the price—literally. #HealthcareCosts #PrescriptionDrugs #PatientSupport #Pharma #HealthTech #Health225Share
